Pfizer and BioNTech launch trial of Omicron-targeted COVID vaccine

13 Sept 07:57 Key points summarised by AI

Pfizer and BioNTech commenced a clinical trial for a new COVID-19 vaccine specifically engineered to target the Omicron variant.
The trial will assess the Omicron-based vaccine's efficacy as a primary three-shot regimen for unvaccinated individuals and as booster doses for those who previously received the original vaccine.
This initiative aims to proactively address concerns about potentially waning protection from current vaccines against Omicron, with regulators now emphasizing clinical studies for new variant-specific vaccine approvals.

Speculation growing over merger between Bhumjaithai and Kla Tham parties

Today 16:46 Key points summarised by AI

A dinner between Bhumjaithai and Kla Tham party leaders sparked rumors of a potential merger, though Bhumjaithai's leader, Anutin, downplayed it as a casual meal.
The meeting is widely interpreted as a strategic message from Bhumjaithai to the Pheu Thai party, signaling alternative support ahead of an upcoming no-confidence debate.
Thailand's Constitution (Section 99) currently prohibits direct mergers of parties with sitting MPs during the House's term, a rule designed to prevent the 'buying and selling' of MPs.
While direct mergers are restricted, MPs can still switch parties if dismissed by a three-fourths party vote or if their party dissolves, allowing for indirect political realignments.
Kla Tham's voting behavior in the censure debate will demonstrate its loyalty to the government, potentially influencing future political dynamics despite current merger restrictions.